Heart Watch Study: a Pragmatic Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

105

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

December 1, 2023

Study Completion Date

June 1, 2024

Conditions
CardioversionAtrial Fibrillation
Interventions
DEVICE

Apple Watch

Participants will be assigned to the Apple Watch arm to assess the impact of individual use of the Apple Watch on patient-reported and clinical utilization outcomes using Hugo.

DEVICE

Withings Move

Participants will be assigned to the Withings Move arm to assess the impact of individual use of the Withings Move on patient-reported and clinical utilization outcomes using Hugo.

Trial Locations (3)

27710

Duke University Medical Center, Durham

55905

Mayo Clinic, Rochester

06510

Yale-New Haven Hospital, New Haven

Sponsors
All Listed Sponsors
collaborator

Mayo Clinic

OTHER

collaborator

Duke University

OTHER

collaborator

National Evaluation System for health Technology Coordinating Center

OTHER

lead

Yale University

OTHER